This Phase II application continues development of the Screener for Opioid Abuse Potential (SOAP), a brief, self-administered measure to identify which chronic pain patients being considered for long-term opioid therapy are at risk for medication-related abuse or aberrant behavior. No validated procedure exists for this purpose. Phase I began a rigorous and methodical scale development process. Concept Mapping procedures integrated input from pain and addiction experts and patients to generate and conceptually evaluate items for a SOAP alpha version. Concept Mapping also facilitated creation of an operational definition of abuse/aberrant behavior in chronic pain patients to be used as the criterion in Phase II. An initial empirical feasibility test, using cross sectional methods, resulted in a beta version of the SOAP. Phase II will continue item selection using prospective methods to create a final version with good reliability and predictive validity. The final version will then be cross-validated. ROC analyses will identify cutoff scores with maximal sensitivity and specificity, and different cutoff values will be examined with respect to pre-test probabilities of abuse and aberrant behavior. Substantial Phase III support has been committed by Endo Pharmaceuticals. The resulting measure should be reliable, valid, and easy to use in practice settings.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44DA015617-02
Application #
6793028
Study Section
Special Emphasis Panel (ZRG1-SSS-D (10))
Program Officer
Hilton, Thomas
Project Start
2002-03-01
Project End
2006-04-30
Budget Start
2004-06-20
Budget End
2005-04-30
Support Year
2
Fiscal Year
2004
Total Cost
$446,971
Indirect Cost
Name
Inflexxion, Inc.
Department
Type
DUNS #
796369155
City
Newton
State
MA
Country
United States
Zip Code
02464
Finkelman, Matthew D; Kulich, Ronald J; Zacharoff, Kevin L et al. (2015) Shortening the Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP-R): A Proof-of-Principle Study for Customized Computer-Based Testing. Pain Med 16:2344-56
Jamison, Robert N; Martel, Marc O; Edwards, Robert R et al. (2014) Validation of a brief Opioid Compliance Checklist for patients with chronic pain. J Pain 15:1092-1101
Butler, Stephen F; Budman, Simon H; Fanciullo, Gilbert J et al. (2010) Cross validation of the current opioid misuse measure to monitor chronic pain patients on opioid therapy. Clin J Pain 26:770-6
Wasan, Ajay D; Butler, Stephen F; Budman, Simon H et al. (2009) Does report of craving opioid medication predict aberrant drug behavior among chronic pain patients? Clin J Pain 25:193-8
Butler, Stephen F; Budman, Simon H; Fernandez, Kathrine C et al. (2007) Development and validation of the Current Opioid Misuse Measure. Pain 130:144-56